SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-011184
Filing Date
2023-02-06
Accepted
2023-02-06 16:14:54
Documents
16
Period of Report
2023-02-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm235588d1_8k.htm   iXBRL 8-K 28234
2 EXHIBIT 99.1 tm235588d1_ex99-1.htm EX-99.1 40328
3 EXHIBIT 99.2 tm235588d1_ex99-2.htm EX-99.2 13851
7 GRAPHIC tm235588d1_ex99-1img001.jpg GRAPHIC 4118
8 GRAPHIC tm235588d1_ex99-2img001.jpg GRAPHIC 4118
  Complete submission text file 0001104659-23-011184.txt   283542

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA coll-20230206.xsd EX-101.SCH 3054
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE coll-20230206_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coll-20230206_pre.xml EX-101.PRE 22609
10 EXTRACTED XBRL INSTANCE DOCUMENT tm235588d1_8k_htm.xml XML 3622
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37372 | Film No.: 23590821
SIC: 2834 Pharmaceutical Preparations